Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients

Eye, Published online: 30 November 2023; doi:10.1038/s41433-023-02848-7Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-naïve and anti-VEGF pretreated patients

Source: Eye - November 30, 2023 Category: Opthalmology Authors: Daniel S. Pereira Raj K. Maturi Kazumasa Akita Vinaya Mahesh Robert B. Bhisitkul Toshiaki Nishihata Eri Sakota Yusuf Ali Emiko Nakamura Padma Bezwada Yoshikazu Nakamura Source Type: research